SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Keith Fauci who wrote (6568)12/29/1998 2:24:00 PM
From: VIXandMore  Respond to of 9523
 
It sounds like this award is more forward looking than backward looking, as the article emphasizes what's in the pipeline (half a dozen probable blockbusters -- worth perhaps $10B per year in incremental revenues) and the likelihood of overtaking MRK as top pharma dog (first in market cap, then in sales), while at the same time noting PFE's very strong recent performance.

Worth a look:
forbes.com

-Bill